Journey Clinical Inc.

  • Home
  • Journey Clinical Inc.
Directions Website

Journey Clinical Inc. Empowering psychotherapists. Healing patients.

Insurance-covered mental healthcare, education & community — all in one place.
➡️ Offering Ketamine-Assisted Psychotherapy (KAP) and Medication Management Journey Clinical is on a mission to transform the growing mental health crisis by accelerating the adoption of frontier treatments that lead to lasting improvements in clinical outcomes. We have built a turnkey healthtech platform to safely and effectively expand access to a powerful modality known as Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy (KAP). In our patient-centered collaborative care model, licensed psychotherapists in the network take on the psychotherapy, while Journey Clinical's in-house medical team takes on patient eligibility, treatment plan and outcome monitoring. Journey Clinical’s platform gives psychotherapists passionate about PAP the infrastructure and support required to become empowered KAP providers, while enabling higher standards of patient care and enhanced clinical outcomes. If you are a licensed psychotherapist, interested patient or supporter of lasting mental health and wellbeing, we invite you to join us.

Attending APA 2026 this week? Be sure to come to tomorrow’s program on the foundations of Ketamine-Assisted Psychotherap...
05/08/2026

Attending APA 2026 this week? Be sure to come to tomorrow’s program on the foundations of Ketamine-Assisted Psychotherapy (KAP), featuring Journey Clinical Lead Clinician Dr. Brigitte Gordon, DNP, PMHNP-BC, and Council of Therapists Chair Dr. Jessica Punzo, Psy.D. Dr. Jessica Punzo!

Thursday, August 6th | 2:30-3:30pm ET
Spotlight Stage (Hall D, Solutions Center, End of Aisles 300 & 400)

The program walks through how clients are assessed for eligibility, what falls within the therapist’s scope, and how the prescriber-therapist relationship works day to day. You’ll gain a clear picture of how KAP treatment plans are developed as well as an inside look into how preparation, dosing, and integration sessions are structured, as well as how KAP can support and deepen the therapeutic work you’re already doing.

22/07/2026

During the Ketamine-Assisted Psychotherapy (KAP) session, we create a safe container where my clients feel really held in the work that they’re doing and able to really deepen into whatever that experience is. It’s incredibly able to be individualized to the needs of whoever I’m working with.”

Texas-based KAP provider Dr. Amy Gorniak, PsyD, walks through the steps of experiencing KAP with a psychotherapist – from the initial referral to Journey Clinical to what comes after the recommended course of 6-8 preparation, dosing, and integration sessions. Amy facilitates KAP dosing sessions either in-person or remotely through Journey Clinical’s collaborative care model. Our medical team manages all medical aspects of her clients’ treatment plans, including eligibility, prescribing, and outcome monitoring, allowing Amy to focus on providing therapeutic support within her scope of practice.

Ready to get started? Visit our link-in-bio to find a therapist.

30/05/2026

Journey Clinical Co-founder & CEO Myriam Barthes recently joined Jeremy Van Wert on the mindfulmutiny podcast to discuss how psychedelics can amplify what’s already present beneath the surface, bringing awareness to the patterns we often work hard to suppress, avoid, or ignore.

As Myriam shares in this clip, insight is only the beginning. Lasting transformation comes through integration: the process of making meaning of those experiences and applying the lessons learned to everyday life through psychotherapy. Journey Clinical partners with more than 2,500 licensed mental health professionals across the U.S. to help patients access safe, effective Ketamine-Assisted Psychotherapy (KAP) with comprehensive clinical support.

You can listen to the full conversation though our link-in-bio.

Highlights from Wednesday evening’s rooftop panel and mixer in Manhattan’s Union Square, where advocates for the Psyched...
23/05/2026

Highlights from Wednesday evening’s rooftop panel and mixer in Manhattan’s Union Square, where advocates for the Psychedelic-Assisted Psychotherapy movement came together to explore what responsible delivery of psychedelic therapy can and should look like as the field moves closer to broader adoption — particularly in light of the recent executive order advancing psychedelic research.

A huge thank you to our panelists for offering their bold perspectives to our community on the infrastructure required to bring these treatments forward safely: rigorous protocols, a strong therapeutic alliance, clinician education, local advocacy, and delivery models that can, in words echoed throughout the evening, “move at the speed of trust.”

At Journey Clinical, our mission has always been to expand safe, equitable access to Psychedelic-Assisted Psychotherapy. Today, with the largest network of PAP providers in the U.S. delivering KAP and Spravato through a collaborative care model — supported by insurance coverage, drug development partnerships, and the clinical infrastructure for both the medical and psychotherapeutic arms of treatment — we are proud to serve as America’s gateway to psychedelics, with safety and responsible care at the heart of our model.

Panelists:
Myriam Barthes, CEO & Co-Founder & Jonathan Sabbagh, Co-Founder & Executive Chairman, 
Greg Kubin, Co-Founder & Partner, 
Dr. Rachel Yehuda, Icahn School of Medicine at Mount Sinai 
Rebecca Love, LCSW, Founder of Plant Parenthood and Journey Clinical KAP Provider

Production Crew:
Photos: 
PR: 
Producers: 
Catering: 
Bar: 
Live Guitar: .tones
AV:

And to everyone who joined us — thank you for being a part of this moment. We hope you’ll continue to stay involved with our community events and online programming. 💜 For those who couldn’t make it, a recording of the panel will be posted shortly and some exciting ways to get involved to celebrate World Psychedelics Day on June 20th from wherever you are. 🎉

President Trump signed an executive order today directing the FDA and DEA to create a “Right to Try” pathway for psyched...
18/04/2026

President Trump signed an executive order today directing the FDA and DEA to create a “Right to Try” pathway for psychedelic treatments for patients with treatment-resistant conditions, such as treatment-resistant depression and C-PTSD.

This is a significant federal step for the broader integration of psychedelic-assisted therapies. As research continues to validate the efficacy of psychedelics in mental health care, we hope that this progress brings us closer to the expansion of more accessible and effective care for those in need.

Today is the official launch of the Journey Clinical Therapist Directory and our fully redesigned patient website to mak...
15/04/2026

Today is the official launch of the Journey Clinical Therapist Directory and our fully redesigned patient website to make it easier to find trusted, qualified providers offering Ketamine-Assisted Psychotherapy across the U.S.

You can now easily explore and filter providers by location, accepted insurance, specialties, and therapeutic approach — all in one place. Whether you have a clear idea of what you’re looking for or are still figuring it out, our directory helps match you with a provider who can best support you through your mental health journey.

You can explore the directory and find a therapist to start KAP with at journeyclinical.com.

In Ketamine-Assisted Psychotherapy (KAP), “set” refers to the internal psychological state of the individual entering th...
07/04/2026

In Ketamine-Assisted Psychotherapy (KAP), “set” refers to the internal psychological state of the individual entering the experience, including emotional state, expectations, intentions, beliefs, fears, personality traits, and psychological preparation. “Setting” refers to the external therapeutic environment, including the treatment space, sensory conditions such as lighting and music, the presence of supportive clinicians, and the broader therapeutic framework surrounding the session. These factors influence how patients experience and interpret treatment.

Clinical research suggests that psychological and environmental context can influence how individuals process and integrate altered states. In KAP, clinicians intentionally structure set and setting to support therapeutic outcomes.

A new Bloomberg article highlights emerging research exploring psychedelics as a potential tool for addiction treatment....
11/03/2026

A new Bloomberg article highlights emerging research exploring psychedelics as a potential tool for addiction treatment. In a recent Johns Hopkins study published in JAMA Network Open, participants who received a single high dose of psilocybin alongside cognitive behavioral therapy had more than six times greater odds of remaining cigarette-free after six months compared with those using ni****ne patches.

Researchers emphasize that larger and more diverse studies are still needed, but the findings add to a growing body of research investigating how psychedelic-assisted therapies may support behavioral change.

Join us next Wednesday for a free panel webinar in celebration of Women's History Month on how Ketamine-Assisted Psychot...
04/03/2026

Join us next Wednesday for a free panel webinar in celebration of Women's History Month on how Ketamine-Assisted Psychotherapy (KAP) is being used to support women's health, including topics such as trauma and identify, relationships, postpartum, navigating motherhood, managing stress, and aging.

Journey Clinical KAP providers Natasha Camille, LCSW, Chrissy Powers, LMFT, and Jessica Tomich Sorci, LMFT, along with Journey Clinical prescriber Samantha Stroeh MSN, AGNP-BC, PMHNP-BC, will share how ketamine can support women experiencing mental health challenges and life transitions. You’ll hear real-world examples of how KAP is integrated into retreats and individual/couples therapy sessions, what it looks like in practice, and the outcomes clinicians are seeing with female-identifying clients.

RSVP here: https://luma.com/kap-womens-health

We hope to see you there!

This  , we’re proud to highlight a few of the Black therapists in the Journey Clinical community who are advancing psych...
25/02/2026

This , we’re proud to highlight a few of the Black therapists in the Journey Clinical community who are advancing psychedelic-assisted care in their communities. Through Ketamine-Assisted Psychotherapy (KAP) and other trauma-informed approaches, these clinicians are creating spaces where clients can feel seen, supported, and empowered in their healing.

This month and every month, we celebrate their leadership and the meaningful impact they’re making in their communities.

Featured Therapists:
LJ Lumpkin III, LMFT nomadhealingpractices.com
Natty Camille, LCSW wildestdreamstherapy.com
Tozia Ware, LPC-MHSP(T), NCC modernhealingco.com
LaTasha Thomas, LPC www.zenholisticscounseling.com

Address


Alerts

Be the first to know and let us send you an email when Journey Clinical Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your practice to be the top-listed clinic?

Share